Total Payments
$12,304
2024 Payments
$1,710
Companies
39
Transactions
538
Medicare Patients
2,857
Medicare Billing
$341,351
Payment Breakdown by Category
Food & Beverage$10,784 (87.6%)
Consulting$1,350 (11.0%)
Education$98.71 (0.8%)
Gifts$71.52 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,784 | 534 | 87.6% |
| Consulting Fee | $1,350 | 1 | 11.0% |
| Education | $98.71 | 2 | 0.8% |
| Gift | $71.52 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,170 | 163 | $0 (2024) |
| Aralez Pharmaceuticals US Inc. | $1,507 | 6 | $0 (2017) |
| Janssen Biotech, Inc. | $718.19 | 30 | $0 (2024) |
| Celgene Corporation | $628.69 | 44 | $0 (2024) |
| Allergan Inc. | $551.59 | 47 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $541.62 | 33 | $0 (2024) |
| Gilead Sciences, Inc. | $486.85 | 25 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $386.17 | 12 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $375.24 | 39 | $0 (2022) |
| AIMMUNE THERAPEUTICS, INC. | $281.52 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,710 | 53 | ABBVIE INC. ($468.44) |
| 2023 | $1,724 | 63 | ABBVIE INC. ($895.53) |
| 2022 | $1,905 | 94 | ABBVIE INC. ($874.25) |
| 2021 | $1,550 | 78 | AbbVie Inc. ($425.65) |
| 2020 | $613.34 | 33 | AbbVie Inc. ($347.85) |
| 2019 | $994.66 | 52 | AbbVie, Inc. ($292.08) |
| 2018 | $1,348 | 92 | AbbVie, Inc. ($492.99) |
| 2017 | $2,459 | 73 | Aralez Pharmaceuticals US Inc. ($1,507) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.40 | General |
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.03 | General |
| 10/30/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $145.61 | General |
| Category: LIVER DISEASE | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/16/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Gastrointestinal AI | ||||||
| 10/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: LIVER DISEASE | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.17 | General |
| 09/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: INFLAM | ||||||
| 09/11/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.97 | General |
| 09/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/29/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $124.87 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/28/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Hepatology / Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 647 | 692 | $373,999 | $77,147 |
| 2022 | 10 | 755 | 806 | $478,753 | $91,574 |
| 2021 | 9 | 730 | 815 | $435,287 | $89,676 |
| 2020 | 10 | 725 | 802 | $458,358 | $82,954 |
Total Patients
2,857
Total Services
3,115
Medicare Billing
$341,351
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 198 | $42,570 | $17,479 | 41.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 64 | 66 | $50,556 | $11,253 | 22.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 56 | 56 | $55,664 | $11,228 | 20.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $33,330 | $11,111 | 33.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 98 | 101 | $81,305 | $10,084 | 12.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 66 | 66 | $62,634 | $7,557 | 12.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $13,039 | $2,818 | 21.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $16,107 | $2,579 | 16.0% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 29 | 35 | $5,495 | $2,058 | 37.5% |
| 43450 | Dilation of esophagus | Facility | 2023 | 30 | 31 | $13,299 | $978.55 | 7.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 88 | 89 | $88,466 | $17,551 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 164 | $35,260 | $14,843 | 42.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 118 | 118 | $38,940 | $13,242 | 34.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 124 | 126 | $101,430 | $12,984 | 12.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 98 | 100 | $94,900 | $10,896 | 11.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 61 | 62 | $47,492 | $10,794 | 22.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 43 | 43 | $32,981 | $4,747 | 14.4% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2022 | 33 | 37 | $5,809 | $2,495 | 43.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 14 | $10,738 | $2,415 | 22.5% |
| 43450 | Dilation of esophagus | Facility | 2022 | 50 | 53 | $22,737 | $1,606 | 7.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 161 | 214 | $46,010 | $19,475 | 42.3% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 78 | 79 | $78,526 | $15,177 | 19.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 121 | 121 | $39,930 | $14,799 | 37.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 127 | 132 | $106,260 | $12,973 | 12.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 48 | 48 | $36,768 | $8,253 | 22.4% |
About Dr. Gary Monash, M.D
Dr. Gary Monash, M.D is a Gastroenterology healthcare provider based in Tucson, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891771846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Monash, M.D has received a total of $12,304 in payments from pharmaceutical and medical device companies, with $1,710 received in 2024. These payments were reported across 538 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($10,784).
As a Medicare-enrolled provider, Monash has provided services to 2,857 Medicare beneficiaries, totaling 3,115 services with total Medicare billing of $341,351. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Tucson, AZ
- Active Since 12/21/2005
- Last Updated 12/18/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1891771846
Products in Payments
- YOSPRALA (Drug) $1,507
- SKYRIZI (Biological) $1,023
- ZEPOSIA (Drug) $753.69
- HUMIRA (Biological) $722.83
- STELARA (Biological) $654.91
- RINVOQ (Biological) $640.34
- Humira (Biological) $616.05
- LINZESS (Drug) $524.28
- OCALIVA (Drug) $386.17
- VIBERZI (Drug) $375.99
- ZENPEP (Drug) $335.29
- TREMFYA (Drug) $278.99
- CIMZIA (Drug) $242.64
- CREON (Drug) $237.57
- Linzess (Drug) $226.59
- Cimzia (Drug) $220.48
- XELJANZ (Drug) $220.38
- REBYOTA (Biological) $178.57
- Creon (Drug) $162.47
- REZDIFFRA (Drug) $145.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Tucson
Rehan Iftikhar, Md, MD
Gastroenterology — Payments: $77,513
Gastroenterology $77,513
Vicki Mcintyre, Msn, Fnp, MSN, FNP
Gastroenterology — Payments: $59,223
Gastroenterology $59,223
Dr. Fadi Deeb, Md, MD
Gastroenterology — Payments: $28,195
Gastroenterology $28,195
Gary Gottlieb, M.d, M.D
Gastroenterology — Payments: $14,834
Gastroenterology $14,834
Craig Gross, M.d, M.D
Gastroenterology — Payments: $13,613
Gastroenterology $13,613
Dr. Charles Krone, M.d, M.D
Gastroenterology — Payments: $11,973
Gastroenterology $11,973